Wu, Guoxin
Keller, Samuel H.
Sardo, Luca
Magliaro, Brian
Zuck, Paul
Balibar, Carl J.
Williams, Claire
Pan, Liuliu
Gregory, Mark
Ton, Kathy
Maxwell, Jill
Cheney, Carol
Rush, Tom
Howell, Bonnie J.
Article History
Received: 25 July 2024
Accepted: 18 September 2024
First Online: 8 October 2024
Declarations
:
: The animal study protocols were approved by the Institutional Animal Care and Use Committee of Merck & Co., Inc. Rahway, NJ, USA and conducted in accordance with the guide for the Care and Use of Laboratory Animals. Informed consent from HIV + donors was obtained from TJU.
: All authors agreed to submit for consideration for publication in this journal.
: G.W., S.H.K., L.S., B.M., P.Z., C.J.B., J.M., C.C., T.R. and B.J.H. are current or former employees of Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc. Rahway, NJ, USA and may hold stock in Merck & Co., Inc. Rahway, NJ, USA. C.W., K.T., M.G. and L.P. are employees or former employees of NanoString Technologies, a Bruker Company declare no competing interests.